Lexaria Bioscience logo

Lexaria Bioscience share price today

(LEXX)

Lexaria Bioscience share price is $2.18 & ₹187.07 as on 7 Jan 2025, 2.30 'hrs' IST

$2.18

-0.11

(-4.8%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Lexaria Bioscience share price in Dollar and Rupees. Guide to invest in Lexaria Bioscience stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lexaria Bioscience, along with analyst recommendations, forecasts, and comprehensive financials.

Lexaria Bioscience share price movements

  • Today's Low: $2.15
    Today's High: $2.43

    Day's Volatility :11.73%

  • 52 Weeks Low: $1.27
    52 Weeks High: $6.85

    52 Weeks Volatility :81.46%

Lexaria Bioscience Returns

PeriodLexaria Bioscience CorpIndex (Russel 2000)
3 Months
-25.16%
0.0%
6 Months
-11.24%
0.0%
1 Year
67.15%
0.0%
3 Years
-46.74%
-19.8%

Lexaria Bioscience Key Statistics

in dollars & INR

Previous Close
$2.29
Open
$2.3
Today's High
$2.43
Today's Low
$2.145
Market Capitalization
$36.7M
Today's Volume
$114.9K
52 Week High
$6.85
52 Week Low
$1.2701
Revenue TTM
$411.0K
EBITDA
$-4.5M
Earnings Per Share (EPS)
$-0.47
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-70.66%

How to invest in Lexaria Bioscience from India?

It is very easy for Indian residents to invest directly in Lexaria Bioscience from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lexaria Bioscience stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lexaria Bioscience or LEXX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lexaria Bioscience or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lexaria Bioscience shares which would translate to 0.394 fractional shares of Lexaria Bioscience as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lexaria Bioscience, in just a few clicks!

Returns in Lexaria Bioscience for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexaria Bioscience investment value today

Current value as on today

₹1,62,347

Returns

₹62,347

(+62.35%)

Returns from Lexaria Bioscience Stock

₹59,124 (+59.12%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Lexaria Bioscience

20%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Lexaria Bioscience on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 20% more investors are searching Lexaria Bioscience in the last 30 days versus the previous period.

Global Institutional Holdings in Lexaria Bioscience

  • Invenomic Capital Management, LP

    2.73%

  • Geode Capital Management, LLC

    0.86%

  • Vanguard Group Inc

    0.62%

  • GenTrust, LLC

    0.34%

  • Raymond James Finl Svs Advisors, Inc.

    0.26%

  • State Street Corp

    0.23%

Analyst Recommendation on Lexaria Bioscience

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Lexaria Bioscience(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Lexaria Bioscience

What analysts predicted

Upside of 358.72%

Current:

$2.18

Target:

$10.00

Insights on Lexaria Bioscience

  • Price Movement

    In the last 1 year, LEXX stock has moved up by 69.6%
  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 151.27K → 84.0K (in $), with an average decrease of 15.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -649.53K → -2.18M (in $), with an average decrease of 98.5% per quarter
  • LEXX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 102.3%

Lexaria Bioscience Financials in INR & Dollars

FY19Y/Y Change
Revenue
$222.6K
↓ 48.62%
Net Income
$-4.2M
↓ 36.38%
Net Profit Margin
-1.9K%
↓ 362.86%
FY20Y/Y Change
Revenue
$384.5K
↑ 72.74%
Net Income
$-4.0M
↓ 3.99%
Net Profit Margin
-1.0K%
↑ 837.75%
FY21Y/Y Change
Revenue
$722.7K
↑ 87.95%
Net Income
$-2.5M
↓ 37.86%
Net Profit Margin
-346.5%
↑ 701.58%
FY22Y/Y Change
Revenue
$255.4K
↓ 64.66%
Net Income
$-7.3M
↑ 190.27%
Net Profit Margin
-2.8K%
↓ 2499.78%
FY23Y/Y Change
Revenue
$226.2K
↓ 11.43%
Net Income
$-6.7M
↓ 8.31%
Net Profit Margin
-2.9K%
↓ 100.08%
FY24Y/Y Change
Revenue
$464.3K
↑ 105.24%
Net Income
$-5.8M
↓ 13.05%
Net Profit Margin
-1.2K%
↑ 1698.11%
Q2 FY23Q/Q Change
Revenue
$93.2K
↑ 166.03%
Net Income
$-2.4M
↑ 82.69%
Net Profit Margin
-2.5K%
↑ 1161.46%
Q3 FY23Q/Q Change
Revenue
$-3.4K
↓ 103.69%
Net Income
$-1.2M
↓ 47.74%
Net Profit Margin
36.1K%
↑ 38646.07%
Q4 FY23Q/Q Change
Revenue
$151.3K
↓ 4506.58%
Net Income
$-1.2M
↓ 4.84%
Net Profit Margin
-779.57%
↓ 36879.74%
Q1 FY24Q/Q Change
Revenue
$145.0K
↓ 4.15%
Net Income
$-649.5K
↓ 44.92%
Net Profit Margin
-447.96%
↑ 331.61%
Q2 FY24Q/Q Change
Revenue
$84.0K
↓ 42.07%
Net Income
$-1.8M
↑ 174.3%
Net Profit Margin
-2.1K%
↓ 1673.1%
Q3 FY24Q/Q Change
Revenue
$84.0K
↑ 0.0%
Net Income
$-2.2M
↑ 22.62%
Net Profit Margin
-2.6K%
↓ 479.88%
FY19Y/Y Change
Profit
$199.7K
↓ 51.06%
FY20Y/Y Change
Profit
$285.2K
↑ 42.78%
FY21Y/Y Change
Profit
$547.4K
↑ 91.96%
FY22Y/Y Change
Profit
$183.6K
↓ 66.47%
FY23Y/Y Change
Profit
$194.7K
↑ 6.08%
FY24Y/Y Change
Profit
$459.5K
↑ 135.97%
Q2 FY23Q/Q Change
Profit
$80.4K
↑ 150.81%
Q3 FY23Q/Q Change
Profit
$-6.9K
↓ 108.54%
Q4 FY23Q/Q Change
Profit
$146.5K
↓ 2233.06%
Q1 FY24Q/Q Change
Profit
$129.1K
↓ 11.87%
Q2 FY24Q/Q Change
Profit
$84.0K
↓ 34.92%
Q3 FY24Q/Q Change
Profit
$84.0K
↑ 0.0%
FY19Y/Y Change
Operating Cash Flow
$-3.0M
↑ 19.36%
Investing Cash Flow
$-769.2K
↑ 394.96%
Financing Cash Flow
$3.3M
↑ 78.48%
FY20Y/Y Change
Operating Cash Flow
$-2.7M
↓ 11.39%
Investing Cash Flow
$-26.8K
↓ 96.51%
Financing Cash Flow
$2.7M
↓ 19.02%
FY21Y/Y Change
Operating Cash Flow
$-4.0M
↑ 49.8%
Investing Cash Flow
$193.9K
↓ 822.27%
Financing Cash Flow
$13.4M
↑ 397.27%
FY22Y/Y Change
Operating Cash Flow
$-4.9M
↑ 22.3%
Investing Cash Flow
$-180.6K
↓ 193.17%
Financing Cash Flow
$-44.6K
↓ 100.33%
Q2 FY23Q/Q Change
Operating Cash Flow
$-1.8M
↑ 44.09%
Investing Cash Flow
$-33.6K
↑ 2.95%
Financing Cash Flow
$1.7M
↑ 15175.06%

Lexaria Bioscience Technicals Summary

Sell

Neutral

Buy

Lexaria Bioscience is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lexaria Bioscience Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lexaria Bioscience Corp
-4.98%
-11.24%
67.15%
-46.74%
-48.88%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lexaria Bioscience Corp
NA
NA
NA
0.0
-0.71
-0.38
NA
0.64
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lexaria Bioscience Corp
Buy
$36.7M
-48.88%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Lexaria Bioscience

learn about working at legal adviser at sbde . co , legal adviser for mr mohamed kaaki, ceo for oversease business group. join linkedin today for free. see who you know at legal adviser at sbde . co , legal adviser for mr mohamed kaaki, ceo for oversease business group, leverage your professional network, and get hired.
Organization
Lexaria Bioscience
Employees
5
CEO
Mr. Michael Shankman CPA
Industry
Miscellaneous

Management People of Lexaria Bioscience

NameTitle
Mr. Michael Shankman CPA
Chief Financial Officer
Ms. Kristin Hamilton
Director of Operations
Vanessa Carle
Head of Legal

Important FAQs about investing in Lexaria Bioscience from India :

What is Lexaria Bioscience share price today?

Lexaria Bioscience share price today stands at $2.18, Open: $2.30 ; Previous Close: $2.29 ; High: $2.43 ; Low: $2.15 ; 52 Week High: $6.85 ; 52 Week Low: $1.27. The stock opens at $2.30, after a previous close of $2.29. The stock reached a daily high of $2.43 and a low of $2.15, with a 52-week high of $6.85 and a 52-week low of $1.27.

Can Indians buy Lexaria Bioscience shares?

Yes, Indians can invest in the Lexaria Bioscience (LEXX) from India.

With INDmoney, you can buy Lexaria Bioscience at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lexaria Bioscience at zero transaction cost.

How can I buy Lexaria Bioscience shares from India?

It is very easy to buy Lexaria Bioscience from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lexaria Bioscience be purchased?

Yes, you can buy fractional shares of Lexaria Bioscience with INDmoney app.

What are the documents required to start investing in Lexaria Bioscience stocks?

To start investing in Lexaria Bioscience, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lexaria Bioscience

Today’s highest price of Lexaria Bioscience (LEXX) is $2.43.

Today’s lowest price of Lexaria Bioscience (LEXX) is $2.15.

What is today's market capitalisation of Lexaria Bioscience

Today's market capitalisation of Lexaria Bioscience LEXX is 36.7M

What is the 52 Week High and Low Range of Lexaria Bioscience

  • 52 Week High

    $6.85

  • 52 Week Low

    $1.27

What are the historical returns of Lexaria Bioscience?

  • 1 Month Returns

    -4.98%

  • 3 Months Returns

    -11.24%

  • 1 Year Returns

    67.15%

  • 5 Years Returns

    -48.88%

Who is the Chief Executive Officer (CEO) of Lexaria Bioscience

Mr. Michael Shankman CPA is the current Chief Executive Officer (CEO) of Lexaria Bioscience.